Litcius/Paper detail

MicroRNA, Diabetes Mellitus and Colorectal Cancer

Hsiuying Wang

2020Biomedicines30 citationsDOIOpen Access PDF

Abstract

Diabetes mellitus (DM) is an endocrinological disorder that is due to either the pancreas not producing enough insulin, or the body does not respond appropriately to insulin. There are many complications of DM such as retinopathy, nephropathy, and peripheral neuropathy. In addition to these complications, DM was reported to be associated with different cancers. In this review, we discuss the association between DM and colorectal cancer (CRC). CRC is the third most commonly diagnosed cancer worldwide that mostly affects older people, however, its incidence and mortality are rising among young people. We discuss the relationship between DM and CRC based on their common microRNA (miRNA) biomarkers. miRNAs are non-coding RNAs playing important functions in cell differentiation, development, regulation of cell cycle, and apoptosis. miRNAs can inhibit cell proliferation and induce apoptosis in CRC cells. miRNAs also can improve glucose tolerance and insulin sensitivity. Therefore, investigating the common miRNA biomarkers of both DM and CRC can shed a light on how these two diseases are correlated and more understanding of the link between these two diseases can help the prevention of both DM and CRC.

Topics & Concepts

Colorectal cancermicroRNADiabetes mellitusMedicineBioinformaticsCancerNephropathyDiabetic retinopathyType 2 Diabetes MellitusPancreatic cancerCancer researchPancreasInsulinOncologyInternal medicineBiologyEndocrinologyGeneticsGeneCancer-related molecular mechanisms researchMicroRNA in disease regulationMetabolism, Diabetes, and Cancer